Clinical Trial Update: Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD [Phase 2]

View source ↗

Summary

Phase 2 open-label study evaluating the safety and effects of MDMA-assisted therapy for post-traumatic stress disorder has completed and results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Lykos Therapeutics | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2021-07-29